Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced an update on its stock buy-back program, revealing the purchase of 5,000 shares on the previous day, adding to a total of 23,505 shares bought back to date. This move, part of an ongoing market buy-back effort, reflects the company’s strategy to manage its share capital actively.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
